AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (January 13, 2009). doi:10.1152/ajpendo.90505.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/E440    most recent
90505.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bokhari, S.
Right arrow Articles by Meyer, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bokhari, S.
Right arrow Articles by Meyer, C.
Submitted on June 11, 2008
Revised on December 19, 2008
Accepted on January 4, 2009

METABOLIC FATE OF PLASMA GLUCOSE DURING HYPERGLYCEMIA IN IMPAIRED GLUCOSE TOLERANCE: EVIDENCE FOR FURTHER EARLY DEFECTS IN THE PATHOGENESIS OF TYPE 2 DIABETES

Syed Bokhari1, Peter Emerson1, Zarmen Israelian1, Anchal Gupta1, and Christian Meyer1*

1 Carl T. Hayden VA Medical Center

* To whom correspondence should be addressed. E-mail: Christian.Meyer{at}va.gov.

We examined the intracellular metabolic fate of plasma glucose during a hyperglycemic clamp in impaired glucose tolerant (IGT; N=21) and normal glucose tolerant subjects (N=10) using a combination of [3-3H] glucose infusion with measurement of [3H] water formation and indirect calorimetry. IGT was associated with ~35% reduced first phase insulin responses, normal second phase insulin response and 25-30% reduced insulin sensitivity, resulting in ~35% reduced plasma glucose disposal. This was coupled with ~55% reduced storage of plasma glucose (P<0.01) and ~15-20% reduced glycolysis of plasma glucose (P<0.03), accounting for ~75 and 25% of the reduction in glucose disposal, respectively. Decreased glucose oxidation accounted for virtually all the decrease in glycolysis. Therefore, non-oxidative glycolysis of plasma glucose in IGT was similar to that in NGT (P>0.9) and accounted for an increased proportion of systemic glucose disposal (p<0.05). We conclude that in IGT, decreased disposal of plasma glucose mainly involves decreased glycogen synthesis and to a lesser extent decreased glycolysis, which is accounted for by decreased glucose oxidation. An increased proportion of plasma glucose hence undergoes non-oxidative glycolysis, representing a novel early abnormality in the pathogenesis of T2DM.




This article has been cited by other articles:


Home page
Diabetes CareHome page
E. L. Dillon and M. Sheffield-Moore
Novel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes: Response to Davidson
Diabetes Care, July 1, 2009; 32(7): e89 - e89.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.